Allied Supreme（4770）株式概要アライド・シュープリーム社はその子会社とともに、中国、アメリカ、台湾でフッ素樹脂を製造・販売している。 詳細4770 ファンダメンタル分析スノーフレーク・スコア評価4/6将来の成長0/6過去の実績2/6財務の健全性6/6配当金3/6報酬当社が推定した公正価値より29.7%で取引されている リスク分析不安定な配当実績 利益率(16.8%)は昨年より低い(24.4%) すべてのリスクチェックを見る4770 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueNT$Current PriceNT$213.508.0% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture07b2016201920222025202620282031Revenue NT$6.8bEarnings NT$1.1bAdvancedSet Fair ValueView all narrativesAllied Supreme Corp. 競合他社CoremaxSymbol: TWSE:4739Market cap: NT$14.3bSan Fu ChemicalSymbol: TWSE:4755Market cap: NT$14.1bNANTEX IndustrySymbol: TWSE:2108Market cap: NT$14.9bChina Steel ChemicalSymbol: TWSE:1723Market cap: NT$20.2b価格と性能株価の高値、安値、推移の概要Allied Supreme過去の株価現在の株価NT$213.5052週高値NT$345.0052週安値NT$203.50ベータ0.751ヶ月の変化-4.47%3ヶ月変化-17.41%1年変化-8.96%3年間の変化-33.80%5年間の変化-5.53%IPOからの変化80.93%最新ニュースValuation Update With 7 Day Price Move • May 26Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$266, the stock trades at a trailing P/E ratio of 26.2x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Negligible returns to shareholders over past three years. Simply Wall St's valuation model estimates the intrinsic value at NT$303 per share.Reported Earnings • May 13First quarter 2026 earnings: EPS and revenues miss analyst expectationsFirst quarter 2026 results: EPS: NT$2.00 (down from NT$2.60 in 1Q 2025). Revenue: NT$1.06b (up 9.6% from 1Q 2025). Net income: NT$201.6m (down 3.0% from 1Q 2025). Profit margin: 19% (down from 22% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 29%. Earnings per share (EPS) also missed analyst estimates by 52%. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.New Risk • Mar 31New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.8% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.3% average weekly change). Profit margins are more than 30% lower than last year (17% net profit margin).Upcoming Dividend • Mar 25Upcoming dividend of NT$6.00 per shareEligible shareholders must have bought the stock before 01 April 2026. Payment date: 30 April 2026. Payout ratio is on the higher end at 88%, however this is supported by cash flows. Trailing yield: 5.3%. Within top quartile of Taiwanese dividend payers (5.3%). Higher than average of industry peers (2.1%).New Risk • Mar 17New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 17% Last year net profit margin: 27% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Profit margins are more than 30% lower than last year (17% net profit margin).Reported Earnings • Mar 17Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: NT$10.20 (down from NT$21.68 in FY 2024). Revenue: NT$4.73b (down 27% from FY 2024). Net income: NT$815.9m (down 53% from FY 2024). Profit margin: 17% (down from 27% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 6.7%. Earnings per share (EPS) also missed analyst estimates by 20%. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.最新情報をもっと見るRecent updatesValuation Update With 7 Day Price Move • May 26Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$266, the stock trades at a trailing P/E ratio of 26.2x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Negligible returns to shareholders over past three years. Simply Wall St's valuation model estimates the intrinsic value at NT$303 per share.Reported Earnings • May 13First quarter 2026 earnings: EPS and revenues miss analyst expectationsFirst quarter 2026 results: EPS: NT$2.00 (down from NT$2.60 in 1Q 2025). Revenue: NT$1.06b (up 9.6% from 1Q 2025). Net income: NT$201.6m (down 3.0% from 1Q 2025). Profit margin: 19% (down from 22% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 29%. Earnings per share (EPS) also missed analyst estimates by 52%. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.New Risk • Mar 31New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.8% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.3% average weekly change). Profit margins are more than 30% lower than last year (17% net profit margin).Upcoming Dividend • Mar 25Upcoming dividend of NT$6.00 per shareEligible shareholders must have bought the stock before 01 April 2026. Payment date: 30 April 2026. Payout ratio is on the higher end at 88%, however this is supported by cash flows. Trailing yield: 5.3%. Within top quartile of Taiwanese dividend payers (5.3%). Higher than average of industry peers (2.1%).New Risk • Mar 17New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 17% Last year net profit margin: 27% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Profit margins are more than 30% lower than last year (17% net profit margin).Reported Earnings • Mar 17Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: NT$10.20 (down from NT$21.68 in FY 2024). Revenue: NT$4.73b (down 27% from FY 2024). Net income: NT$815.9m (down 53% from FY 2024). Profit margin: 17% (down from 27% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 6.7%. Earnings per share (EPS) also missed analyst estimates by 20%. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.Declared Dividend • Mar 11Dividend reduced to NT$6.00Dividend of NT$6.00 is 50% lower than last year. Ex-date: 1st April 2026 Payment date: 30th April 2026 Dividend yield will be 2.3%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by both earnings (88% earnings payout ratio) and cash flows (66% cash payout ratio). The dividend has increased by an average of 23% per year over the past 5 years and payments have been stable during that time. EPS is expected to grow by 26% over the next year, which should provide support to the dividend and adequate earnings cover.Valuation Update With 7 Day Price Move • Mar 11Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$262, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 19x in the Chemicals industry in Taiwan. Total loss to shareholders of 9.0% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at NT$248 per share.New Risk • Mar 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.お知らせ • Mar 10+ 1 more updateAllied Supreme Corp., Annual General Meeting, Jun 02, 2026Allied Supreme Corp., Annual General Meeting, Jun 02, 2026. Location: no,20, hsien kung nan 2nd rd., siansi township, changhua county TaiwanMajor Estimate Revision • Jan 15Consensus revenue estimates fall by 14%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from NT$5.50b to NT$4.73b. EPS estimate fell from NT$14.78 to NT$10.91 per share. Net income forecast to grow 17% next year vs 35% growth forecast for Chemicals industry in Taiwan. Consensus price target of NT$366 unchanged from last update. Share price fell 6.1% to NT$223 over the past week.Reported Earnings • Nov 17Third quarter 2025 earnings: EPS misses analyst expectationsThird quarter 2025 results: EPS: NT$3.05 (down from NT$5.28 in 3Q 2024). Revenue: NT$1.40b (down 21% from 3Q 2024). Net income: NT$244.0m (down 42% from 3Q 2024). Profit margin: 18% (down from 24% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 23%. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 6.3% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has fallen by 12% per year whereas the company’s share price has fallen by 9% per year.Buy Or Sell Opportunity • Sep 08Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 32% to NT$320. The fair value is estimated to be NT$264, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 5.1%. Revenue is forecast to grow by 5.4% in a year. Earnings are forecast to grow by 7.5% in the next year.Price Target Changed • Aug 17Price target increased by 15% to NT$367Up from NT$320, the current price target is an average from 4 analysts. New target price is 34% above last closing price of NT$275. Stock is down 29% over the past year. The company is forecast to post earnings per share of NT$14.78 for next year compared to NT$21.68 last year.Reported Earnings • Aug 13Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: NT$2.75 (down from NT$5.01 in 2Q 2024). Revenue: NT$1.31b (down 17% from 2Q 2024). Net income: NT$220.2m (down 45% from 2Q 2024). Profit margin: 17% (down from 25% in 2Q 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates by 38%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 3.6% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Aug 08Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$307, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 34% over the past three years.Valuation Update With 7 Day Price Move • Jun 20Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$275, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 16% over the past three years.お知らせ • May 30Allied Supreme Corp. Approves Board ElectionsAllied Supreme Corp. at its 2025 Annual General Shareholders meeting held on May 29, 2025, approved the election of Director: Hou, Chia-Sheng and Independent Director: Lu, Chien-Jung, Independent Director: Wang, Kui-Ching, Independent Director: Chien, Yu-Kuo and Independent Director: Chen, Yun-Chang.Reported Earnings • May 13First quarter 2025 earnings: EPS and revenues miss analyst expectationsFirst quarter 2025 results: EPS: NT$2.60 (down from NT$6.14 in 1Q 2024). Revenue: NT$965.9m (down 35% from 1Q 2024). Net income: NT$207.8m (down 58% from 1Q 2024). Profit margin: 22% (down from 33% in 1Q 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.0%. Earnings per share (EPS) also missed analyst estimates by 5.9%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.お知らせ • May 01Allied Supreme Corp. to Report Q1, 2025 Results on May 08, 2025Allied Supreme Corp. announced that they will report Q1, 2025 results on May 08, 2025Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$234, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 17x in the Chemicals industry in Taiwan. Negligible returns to shareholders over past three years.Valuation Update With 7 Day Price Move • Mar 31Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to NT$272, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 16% over the past three years.Major Estimate Revision • Mar 20Consensus revenue estimates fall by 14%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from NT$7.23b to NT$6.20b. EPS estimate fell from NT$24.35 to NT$18.42 per share. Net income forecast to shrink 15% next year vs 18% growth forecast for Chemicals industry in Taiwan . Consensus price target down from NT$434 to NT$384. Share price was steady at NT$343 over the past week.Price Target Changed • Mar 19Price target decreased by 14% to NT$384Down from NT$444, the current price target is an average from 2 analysts. New target price is 11% above last closing price of NT$345. Stock is down 14% over the past year. The company is forecast to post earnings per share of NT$18.42 for next year compared to NT$21.68 last year.Reported Earnings • Mar 15Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: NT$21.68 (up from NT$21.22 in FY 2023). Revenue: NT$6.46b (up 13% from FY 2023). Net income: NT$1.73b (up 2.9% from FY 2023). Profit margin: 27% (down from 30% in FY 2023). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.7%. Revenue is forecast to grow 7.1% p.a. on average during the next 2 years, compared to a 4.9% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 11% per year.分析記事 • Mar 13Allied Supreme (TWSE:4770) Has Announced A Dividend Of NT$12.00Allied Supreme Corp. ( TWSE:4770 ) has announced that it will pay a dividend of NT$12.00 per share on the 30th of...お知らせ • Mar 13Allied Supreme Corp., Annual General Meeting, May 29, 2025Allied Supreme Corp., Annual General Meeting, May 29, 2025, at 10:00 Taipei Standard Time. Location: no,300, ch`ing fu rd., siansi township, changhua county TaiwanDeclared Dividend • Mar 13Dividend of NT$12.00 announcedDividend of NT$12.00 is the same as last year. Ex-date: 27th March 2025 Payment date: 30th April 2025 Dividend yield will be 3.5%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by both earnings (56% earnings payout ratio) and cash flows (75% cash payout ratio). The dividend has increased by an average of 29% per year over the past 4 years and payments have been stable during that time. EPS is expected to grow by 19% over the next 2 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Mar 12Allied Supreme Corp. Announces Cash Dividend Distribution for the Year 2024, Payable on April 30, 2025Allied Supreme Corp. announced cash dividend distribution for the year 2024. Type and monetary amount of common stock dividend distribution: Cash dividends: TWD 959,712,000 (TWD 12 distributed per share). Ex-rights (ex-dividend) trading date: March 27, 2025; Ex-rights (ex-dividend) record date: April 4, 2025. Payment date of common stock cash dividend distribution: April 30, 2025.Valuation Update With 7 Day Price Move • Mar 06Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$372, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 68% over the past three years.お知らせ • Feb 28Allied Supreme Corp. to Report Q4, 2024 Results on Mar 07, 2025Allied Supreme Corp. announced that they will report Q4, 2024 results on Mar 07, 2025New Risk • Feb 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Valuation Update With 7 Day Price Move • Feb 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$330, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 40% over the past three years.分析記事 • Feb 14There's No Escaping Allied Supreme Corp.'s (TWSE:4770) Muted EarningsAllied Supreme Corp.'s ( TWSE:4770 ) price-to-earnings (or "P/E") ratio of 14.9x might make it look like a buy right...分析記事 • Dec 16Why You Should Care About Allied Supreme's (TWSE:4770) Strong Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...Reported Earnings • Nov 15Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behindThird quarter 2024 results: EPS: NT$5.28 (up from NT$4.82 in 3Q 2023). Revenue: NT$1.77b (up 44% from 3Q 2023). Net income: NT$422.1m (up 10% from 3Q 2023). Profit margin: 24% (down from 31% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) missed analyst estimates by 5.2%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 9% per year.お知らせ • Nov 01Allied Supreme Corp. to Report Q3, 2024 Results on Nov 08, 2024Allied Supreme Corp. announced that they will report Q3, 2024 results on Nov 08, 2024分析記事 • Sep 04Investors Shouldn't Overlook The Favourable Returns On Capital At Allied Supreme (TWSE:4770)What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...Reported Earnings • Aug 12Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: NT$5.01 (up from NT$4.75 in 2Q 2023). Revenue: NT$1.59b (up 8.4% from 2Q 2023). Net income: NT$400.4m (up 6.6% from 2Q 2023). Profit margin: 25% (in line with 2Q 2023). Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) also missed analyst estimates by 10%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 4.7% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 19% per year and the company’s share price has also increased by 19% per year.分析記事 • Aug 08A Look At The Intrinsic Value Of Allied Supreme Corp. (TWSE:4770)Key Insights Allied Supreme's estimated fair value is NT$463 based on 2 Stage Free Cash Flow to Equity Allied Supreme's...Buy Or Sell Opportunity • Aug 05Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to NT$348. The fair value is estimated to be NT$462, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% over the last 3 years. Earnings per share has grown by 25%. Revenue is forecast to grow by 19% in a year. Earnings are forecast to grow by 16% in the next year.お知らせ • Aug 01Allied Supreme Corp. to Report Q2, 2024 Results on Aug 08, 2024Allied Supreme Corp. announced that they will report Q2, 2024 results on Aug 08, 2024分析記事 • Jun 26Many Still Looking Away From Allied Supreme Corp. (TWSE:4770)Allied Supreme Corp.'s ( TWSE:4770 ) price-to-earnings (or "P/E") ratio of 19.9x might make it look like a buy right...Reported Earnings • May 18First quarter 2024 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2024 results: EPS: NT$6.14 (down from NT$6.81 in 1Q 2023). Revenue: NT$1.48b (down 13% from 1Q 2023). Net income: NT$489.9m (down 9.0% from 1Q 2023). Profit margin: 33% (up from 32% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue exceeded analyst estimates by 4.9%. Earnings per share (EPS) also surpassed analyst estimates by 18%. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 6.6% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 22% per year.分析記事 • May 08Allied Supreme (TWSE:4770) Is Aiming To Keep Up Its Impressive ReturnsFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...お知らせ • May 02Allied Supreme Corp. to Report Q1, 2024 Results on May 09, 2024Allied Supreme Corp. announced that they will report Q1, 2024 results on May 09, 2024Price Target Changed • Mar 22Price target increased by 14% to NT$419Up from NT$369, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of NT$415. Stock is up 40% over the past year. The company is forecast to post earnings per share of NT$22.89 for next year compared to NT$21.22 last year.分析記事 • Mar 21We Think That There Are More Issues For Allied Supreme (TWSE:4770) Than Just Sluggish EarningsAllied Supreme Corp.'s ( TWSE:4770 ) stock showed strength, with investors undeterred by its weak earnings report...Upcoming Dividend • Mar 21Upcoming dividend of NT$12.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 30 April 2024. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 2.8%. Lower than top quartile of Taiwanese dividend payers (4.7%). Lower than average of industry peers (4.1%).Reported Earnings • Mar 16Full year 2023 earnings: Revenues and EPS in line with analyst expectationsFull year 2023 results: EPS: NT$21.22 (down from NT$22.54 in FY 2022). Revenue: NT$5.69b (down 7.3% from FY 2022). Net income: NT$1.68b (down 5.2% from FY 2022). Profit margin: 30% (in line with FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 8.4% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 33% per year whereas the company’s share price has increased by 34% per year.Price Target Changed • Mar 13Price target increased by 13% to NT$393Up from NT$348, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of NT$387. Stock is up 21% over the past year. The company is forecast to post earnings per share of NT$21.17 for next year compared to NT$22.54 last year.分析記事 • Mar 11Allied Supreme (TWSE:4770) Is Paying Out A Dividend Of NT$12.00Allied Supreme Corp.'s ( TWSE:4770 ) investors are due to receive a payment of NT$12.00 per share on 30th of April. The...Declared Dividend • Mar 10Dividend of NT$12.00 announcedDividend of NT$12.00 is the same as last year. Ex-date: 28th March 2024 Payment date: 30th April 2024 Dividend yield will be 3.1%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by earnings (53% earnings payout ratio) but not covered by cash flows (294% cash payout ratio). The dividend has increased by an average of 41% per year over the past 3 years and payments have been stable during that time. EPS is expected to grow by 14% over the next 2 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Mar 09+ 1 more updateAllied Supreme Corp. Announces Cash Dividend, Payable on April 30, 2024Allied Supreme Corp. announced cash dividend of TWD 959,712,000 (TWD 12 per share). Ex-rights (ex-dividend) trading date: March 28, 2024. Ex-rights (ex-dividend) record date: April 5, 2024. Payment date of common stock cash dividend distribution: April 30, 2024.Valuation Update With 7 Day Price Move • Feb 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$405, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 24x in the Chemicals industry in Taiwan. Total returns to shareholders of 178% over the past three years.分析記事 • Feb 26Allied Supreme Corp.'s (TWSE:4770) Low P/E No Reason For ExcitementWith a price-to-earnings (or "P/E") ratio of 16.7x Allied Supreme Corp. ( TWSE:4770 ) may be sending bullish signals at...Reported Earnings • Nov 17Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2023 results: EPS: NT$4.82 (down from NT$5.91 in 3Q 2022). Revenue: NT$1.23b (down 19% from 3Q 2022). Net income: NT$383.5m (down 18% from 3Q 2022). Profit margin: 31% (in line with 3Q 2022). Revenue missed analyst estimates by 9.7%. Earnings per share (EPS) exceeded analyst estimates by 5.9%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 41% per year whereas the company’s share price has increased by 38% per year.Valuation Update With 7 Day Price Move • Nov 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$365, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 21x in the Chemicals industry in Taiwan. Total returns to shareholders of 196% over the past three years.Price Target Changed • Nov 10Price target increased by 8.9% to NT$348Up from NT$319, the current price target is an average from 3 analysts. New target price is 9.5% above last closing price of NT$318. Stock is up 2.4% over the past year. The company is forecast to post earnings per share of NT$21.14 for next year compared to NT$22.54 last year.Reported Earnings • Aug 10Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: NT$4.75 (down from NT$5.66 in 2Q 2022). Revenue: NT$1.46b (down 8.0% from 2Q 2022). Net income: NT$375.6m (down 15% from 2Q 2022). Profit margin: 26% (down from 28% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 9.2%. Earnings per share (EPS) also missed analyst estimates by 13%. Revenue is forecast to grow 7.6% p.a. on average during the next 2 years, compared to a 5.1% growth forecast for the Chemicals industry in Taiwan.Price Target Changed • May 11Price target decreased by 16% to NT$339Down from NT$405, the current price target is an average from 2 analysts. New target price is 23% above last closing price of NT$275. Stock is up 4.8% over the past year. The company is forecast to post earnings per share of NT$23.67 for next year compared to NT$22.54 last year.Reported Earnings • May 10First quarter 2023 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2023 results: EPS: NT$6.81 (up from NT$4.58 in 1Q 2022). Revenue: NT$1.70b (up 23% from 1Q 2022). Net income: NT$538.2m (up 50% from 1Q 2022). Profit margin: 32% (up from 26% in 1Q 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 4.9%. Earnings per share (EPS) also surpassed analyst estimates by 22%. Revenue is forecast to grow 9.7% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Taiwan are expected to remain flat.Buying Opportunity • Apr 24Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be NT$370, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has grown by 51%. Revenue is forecast to grow by 24% in 2 years. Earnings is forecast to grow by 21% in the next 2 years.Buying Opportunity • Mar 28Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 10%. The fair value is estimated to be NT$368, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has grown by 51%. Revenue is forecast to grow by 24% in 2 years. Earnings is forecast to grow by 21% in the next 2 years.Reported Earnings • Mar 24Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: NT$22.54 (up from NT$13.94 in FY 2021). Revenue: NT$6.14b (up 60% from FY 2021). Net income: NT$1.78b (up 84% from FY 2021). Profit margin: 29% (up from 25% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.9%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 2.1% growth forecast for the Chemicals industry in Taiwan.Price Target Changed • Mar 21Price target decreased by 9.0% to NT$380Down from NT$417, the current price target is an average from 2 analysts. New target price is 29% above last closing price of NT$294. Stock is up 19% over the past year. The company is forecast to post earnings per share of NT$21.48 for next year compared to NT$13.94 last year.Upcoming Dividend • Mar 17Upcoming dividend of NT$12.00 per share at 2.5% yieldEligible shareholders must have bought the stock before 24 March 2023. Payment date: 28 April 2023. Payout ratio is a comfortable 39% and the cash payout ratio is 96%. Trailing yield: 2.5%. Lower than top quartile of Taiwanese dividend payers (6.2%). Lower than average of industry peers (6.6%).Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Nov 10Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2022 results: EPS: NT$5.91 (up from NT$4.01 in 3Q 2021). Revenue: NT$1.53b (up 48% from 3Q 2021). Net income: NT$467.0m (up 68% from 3Q 2021). Profit margin: 31% (up from 27% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 6.5%. Earnings per share (EPS) exceeded analyst estimates by 7.4%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Taiwan are expected to remain flat.Valuation Update With 7 Day Price Move • Oct 13Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to NT$285, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in Taiwan. Total returns to shareholders of 32% over the past year. Simply Wall St's valuation model estimates the intrinsic value at NT$567 per share.Valuation Update With 7 Day Price Move • Aug 22Investor sentiment improved over the past weekAfter last week's 21% share price gain to NT$320, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Chemicals industry in Taiwan. Total returns to shareholders of 51% over the past year. Simply Wall St's valuation model estimates the intrinsic value at NT$595 per share.Reported Earnings • Aug 13Second quarter 2022 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2022 results: EPS: NT$5.65 (up from NT$3.04 in 2Q 2021). Revenue: NT$1.59b (up 78% from 2Q 2021). Net income: NT$444.2m (up 112% from 2Q 2021). Profit margin: 28% (up from 23% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 9.1%. Earnings per share (EPS) also surpassed analyst estimates by 15%. Over the next year, revenue is forecast to grow 29% compared to a 1.7% decline forecast for the industry in Taiwan.Reported Earnings • May 12First quarter 2022 earnings: EPS exceeds analyst expectationsFirst quarter 2022 results: EPS: NT$4.58 (up from NT$2.79 in 1Q 2021). Revenue: NT$1.38b (up 81% from 1Q 2021). Net income: NT$359.5m (up 87% from 1Q 2021). Profit margin: 26% (in line with 1Q 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.1%. Over the next year, revenue is forecast to grow 34% while the industry in Taiwan is not expected to grow.Reported Earnings • Mar 30Full year 2021 earnings released: EPS: NT$13.94 (vs NT$7.65 in FY 2020)Full year 2021 results: EPS: NT$13.94 (up from NT$7.65 in FY 2020). Revenue: NT$3.83b (up 46% from FY 2020). Net income: NT$966.3m (up 84% from FY 2020). Profit margin: 25% (up from 20% in FY 2020). The increase in margin was driven by higher revenue.Upcoming Dividend • Mar 24Upcoming dividend of NT$8.00 per shareEligible shareholders must have bought the stock before 31 March 2022. Payment date: 29 April 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Taiwanese dividend payers (5.4%). Lower than average of industry peers (6.3%).Valuation Update With 7 Day Price Move • Dec 31Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$291, the stock trades at a trailing P/E ratio of 22.3x. Average trailing P/E is 19x in the Chemicals industry in Taiwan. Total returns to shareholders of 118% over the past year.Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS NT$4.01 (vs NT$2.40 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: NT$1.04b (up 37% from 3Q 2020). Net income: NT$277.9m (up 69% from 3Q 2020). Profit margin: 27% (up from 22% in 3Q 2020). The increase in margin was driven by higher revenue.Reported Earnings • Aug 05First quarter 2021 earnings released: EPS NT$2.79 (vs NT$0.60 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: NT$763.5m (up 83% from 1Q 2020). Net income: NT$191.8m (up 367% from 1Q 2020). Profit margin: 25% (up from 9.8% in 1Q 2020). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • May 18Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to NT$200, the stock trades at a trailing P/E ratio of 26.1x. Average trailing P/E is 15x in the Chemicals industry in Taiwan.Reported Earnings • Apr 28Full year 2020 earnings released: EPS NT$7.65 (vs NT$7.30 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: NT$2.63b (up 1.8% from FY 2019). Net income: NT$526.4m (up 5.3% from FY 2019). Profit margin: 20% (in line with FY 2019).分析記事 • Apr 28What Allied Supreme Corp.'s (GTSM:4770) 36% Share Price Gain Is Not Telling YouAllied Supreme Corp. ( GTSM:4770 ) shares have continued their recent momentum with a 36% gain in the last month alone...Valuation Update With 7 Day Price Move • Apr 21Investor sentiment improved over the past weekAfter last week's 17% share price gain to NT$234, the stock trades at a trailing P/E ratio of 56.2x. Average trailing P/E is 21x in the Chemicals industry in Taiwan.分析記事 • Apr 16Estimating The Intrinsic Value Of Allied Supreme Corp. (GTSM:4770)In this article we are going to estimate the intrinsic value of Allied Supreme Corp. ( GTSM:4770 ) by projecting its...お知らせ • Mar 12Allied Supreme Corp., Annual General Meeting, May 28, 2021Allied Supreme Corp., Annual General Meeting, May 28, 2021.Is New 90 Day High Low • Feb 24New 90-day high: NT$161The company is up 19% from its price of NT$135 on 26 November 2020. The Taiwanese market is also up 19% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is up 10.0% over the same period.Is New 90 Day High Low • Jan 21New 90-day high: NT$143The company is up 21% from its price of NT$119 on 23 October 2020. The Taiwanese market is also up 21% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is up 11% over the same period.分析記事 • Dec 28Boasting A 11% Return On Equity, Is Allied Supreme Corp. (GTSM:4770) A Top Quality Stock?Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...Valuation Update With 7 Day Price Move • Nov 16Market bids up stock over the past weekAfter last week's 16% share price gain to NT$138, the stock is trading at a trailing P/E ratio of 33.1x, up from the previous P/E ratio of 28.4x. This compares to an average P/E of 18x in the Chemicals industry in Taiwan.Valuation Update With 7 Day Price Move • Nov 12Market bids up stock over the past weekAfter last week's 15% share price gain to NT$138, the stock is trading at a trailing P/E ratio of 33.1x, up from the previous P/E ratio of 28.7x. This compares to an average P/E of 21x in the Chemicals industry in Taiwan.株主還元4770TW ChemicalsTW 市場7D-10.1%-3.0%-2.1%1Y-9.0%81.3%98.5%株主還元を見る業界別リターン: 4770過去 1 年間で81.3 % の収益を上げたTW Chemicals業界を下回りました。リターン対市場: 4770は、過去 1 年間で98.5 % のリターンを上げたTW市場を下回りました。価格変動Is 4770's price volatile compared to industry and market?4770 volatility4770 Average Weekly Movement7.0%Chemicals Industry Average Movement7.1%Market Average Movement6.3%10% most volatile stocks in TW Market12.2%10% least volatile stocks in TW Market2.5%安定した株価: 4770 、 TW市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 4770の 週次ボラティリティ ( 7% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1981n/aChiao-Sheng Howww.alliedsupreme.comアライドシュプリーム社は、子会社とともに中国、アメリカ、台湾でフッ素樹脂の製造・販売を行っている。フッ素樹脂材料、ライニング製品、コーティング、射出成形製品、オーバーフローシンク/タンク、PTFEマイクロパウダー、PTFEコンパウンドなどのカスタマイズ製品、IC/TFT-LCD、製薬、生化学、石油化学、伝統的な化学産業の化学システム設計と統合ニーズのためのソリューションを提供している。また、ふっ素樹脂シート、チューブ、ロッド、タンク、タワー、熱交換器、チューブ、ふっ素樹脂表面処理、化学精製・リサイクルシステム設備、電子化学品貯蔵・輸送設備も提供している。また、新しい表面処理法と薬液製剤、高周波フッ素基板材料、特殊フッ素材料マイクロポーラス、フッ素複合材料、改質フッ素材料とホットメルトフッ素材料の製造ライン、フッ素チューブ材料の加工装置も開発している。半導体、パネル、石油化学産業向け。アライド・シュープリーム社は1981年に設立され、本社は台湾の台北市にある。もっと見るAllied Supreme Corp. 基礎のまとめAllied Supreme の収益と売上を時価総額と比較するとどうか。4770 基礎統計学時価総額NT$17.07b収益（TTM）NT$809.71m売上高(TTM)NT$4.82b21.1xPER（株価収益率3.5xP/Sレシオ4770 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計4770 損益計算書（TTM）収益NT$4.82b売上原価NT$3.24b売上総利益NT$1.58bその他の費用NT$766.68m収益NT$809.71m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）10.12グロス・マージン32.71%純利益率16.80%有利子負債／自己資本比率5.5%4770 の長期的なパフォーマンスは？過去の実績と比較を見る配当金2.8%現在の配当利回り59%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/13 03:06終値2026/06/12 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Allied Supreme Corp. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Yuhan ChengMasterlink Securities Investment AdvisoryJia-hong YehSinoPac Securities Investment ServiceKan-Chi LeeYuanta Research
Valuation Update With 7 Day Price Move • May 26Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$266, the stock trades at a trailing P/E ratio of 26.2x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Negligible returns to shareholders over past three years. Simply Wall St's valuation model estimates the intrinsic value at NT$303 per share.
Reported Earnings • May 13First quarter 2026 earnings: EPS and revenues miss analyst expectationsFirst quarter 2026 results: EPS: NT$2.00 (down from NT$2.60 in 1Q 2025). Revenue: NT$1.06b (up 9.6% from 1Q 2025). Net income: NT$201.6m (down 3.0% from 1Q 2025). Profit margin: 19% (down from 22% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 29%. Earnings per share (EPS) also missed analyst estimates by 52%. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
New Risk • Mar 31New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.8% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.3% average weekly change). Profit margins are more than 30% lower than last year (17% net profit margin).
Upcoming Dividend • Mar 25Upcoming dividend of NT$6.00 per shareEligible shareholders must have bought the stock before 01 April 2026. Payment date: 30 April 2026. Payout ratio is on the higher end at 88%, however this is supported by cash flows. Trailing yield: 5.3%. Within top quartile of Taiwanese dividend payers (5.3%). Higher than average of industry peers (2.1%).
New Risk • Mar 17New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 17% Last year net profit margin: 27% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Profit margins are more than 30% lower than last year (17% net profit margin).
Reported Earnings • Mar 17Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: NT$10.20 (down from NT$21.68 in FY 2024). Revenue: NT$4.73b (down 27% from FY 2024). Net income: NT$815.9m (down 53% from FY 2024). Profit margin: 17% (down from 27% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 6.7%. Earnings per share (EPS) also missed analyst estimates by 20%. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • May 26Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$266, the stock trades at a trailing P/E ratio of 26.2x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Negligible returns to shareholders over past three years. Simply Wall St's valuation model estimates the intrinsic value at NT$303 per share.
Reported Earnings • May 13First quarter 2026 earnings: EPS and revenues miss analyst expectationsFirst quarter 2026 results: EPS: NT$2.00 (down from NT$2.60 in 1Q 2025). Revenue: NT$1.06b (up 9.6% from 1Q 2025). Net income: NT$201.6m (down 3.0% from 1Q 2025). Profit margin: 19% (down from 22% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 29%. Earnings per share (EPS) also missed analyst estimates by 52%. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
New Risk • Mar 31New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.8% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.3% average weekly change). Profit margins are more than 30% lower than last year (17% net profit margin).
Upcoming Dividend • Mar 25Upcoming dividend of NT$6.00 per shareEligible shareholders must have bought the stock before 01 April 2026. Payment date: 30 April 2026. Payout ratio is on the higher end at 88%, however this is supported by cash flows. Trailing yield: 5.3%. Within top quartile of Taiwanese dividend payers (5.3%). Higher than average of industry peers (2.1%).
New Risk • Mar 17New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 17% Last year net profit margin: 27% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Profit margins are more than 30% lower than last year (17% net profit margin).
Reported Earnings • Mar 17Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: NT$10.20 (down from NT$21.68 in FY 2024). Revenue: NT$4.73b (down 27% from FY 2024). Net income: NT$815.9m (down 53% from FY 2024). Profit margin: 17% (down from 27% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 6.7%. Earnings per share (EPS) also missed analyst estimates by 20%. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
Declared Dividend • Mar 11Dividend reduced to NT$6.00Dividend of NT$6.00 is 50% lower than last year. Ex-date: 1st April 2026 Payment date: 30th April 2026 Dividend yield will be 2.3%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by both earnings (88% earnings payout ratio) and cash flows (66% cash payout ratio). The dividend has increased by an average of 23% per year over the past 5 years and payments have been stable during that time. EPS is expected to grow by 26% over the next year, which should provide support to the dividend and adequate earnings cover.
Valuation Update With 7 Day Price Move • Mar 11Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$262, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 19x in the Chemicals industry in Taiwan. Total loss to shareholders of 9.0% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at NT$248 per share.
New Risk • Mar 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
お知らせ • Mar 10+ 1 more updateAllied Supreme Corp., Annual General Meeting, Jun 02, 2026Allied Supreme Corp., Annual General Meeting, Jun 02, 2026. Location: no,20, hsien kung nan 2nd rd., siansi township, changhua county Taiwan
Major Estimate Revision • Jan 15Consensus revenue estimates fall by 14%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from NT$5.50b to NT$4.73b. EPS estimate fell from NT$14.78 to NT$10.91 per share. Net income forecast to grow 17% next year vs 35% growth forecast for Chemicals industry in Taiwan. Consensus price target of NT$366 unchanged from last update. Share price fell 6.1% to NT$223 over the past week.
Reported Earnings • Nov 17Third quarter 2025 earnings: EPS misses analyst expectationsThird quarter 2025 results: EPS: NT$3.05 (down from NT$5.28 in 3Q 2024). Revenue: NT$1.40b (down 21% from 3Q 2024). Net income: NT$244.0m (down 42% from 3Q 2024). Profit margin: 18% (down from 24% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 23%. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 6.3% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has fallen by 12% per year whereas the company’s share price has fallen by 9% per year.
Buy Or Sell Opportunity • Sep 08Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 32% to NT$320. The fair value is estimated to be NT$264, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 5.1%. Revenue is forecast to grow by 5.4% in a year. Earnings are forecast to grow by 7.5% in the next year.
Price Target Changed • Aug 17Price target increased by 15% to NT$367Up from NT$320, the current price target is an average from 4 analysts. New target price is 34% above last closing price of NT$275. Stock is down 29% over the past year. The company is forecast to post earnings per share of NT$14.78 for next year compared to NT$21.68 last year.
Reported Earnings • Aug 13Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: NT$2.75 (down from NT$5.01 in 2Q 2024). Revenue: NT$1.31b (down 17% from 2Q 2024). Net income: NT$220.2m (down 45% from 2Q 2024). Profit margin: 17% (down from 25% in 2Q 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates by 38%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 3.6% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Aug 08Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$307, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 34% over the past three years.
Valuation Update With 7 Day Price Move • Jun 20Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$275, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 16% over the past three years.
お知らせ • May 30Allied Supreme Corp. Approves Board ElectionsAllied Supreme Corp. at its 2025 Annual General Shareholders meeting held on May 29, 2025, approved the election of Director: Hou, Chia-Sheng and Independent Director: Lu, Chien-Jung, Independent Director: Wang, Kui-Ching, Independent Director: Chien, Yu-Kuo and Independent Director: Chen, Yun-Chang.
Reported Earnings • May 13First quarter 2025 earnings: EPS and revenues miss analyst expectationsFirst quarter 2025 results: EPS: NT$2.60 (down from NT$6.14 in 1Q 2024). Revenue: NT$965.9m (down 35% from 1Q 2024). Net income: NT$207.8m (down 58% from 1Q 2024). Profit margin: 22% (down from 33% in 1Q 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.0%. Earnings per share (EPS) also missed analyst estimates by 5.9%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
お知らせ • May 01Allied Supreme Corp. to Report Q1, 2025 Results on May 08, 2025Allied Supreme Corp. announced that they will report Q1, 2025 results on May 08, 2025
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$234, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 17x in the Chemicals industry in Taiwan. Negligible returns to shareholders over past three years.
Valuation Update With 7 Day Price Move • Mar 31Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to NT$272, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 16% over the past three years.
Major Estimate Revision • Mar 20Consensus revenue estimates fall by 14%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from NT$7.23b to NT$6.20b. EPS estimate fell from NT$24.35 to NT$18.42 per share. Net income forecast to shrink 15% next year vs 18% growth forecast for Chemicals industry in Taiwan . Consensus price target down from NT$434 to NT$384. Share price was steady at NT$343 over the past week.
Price Target Changed • Mar 19Price target decreased by 14% to NT$384Down from NT$444, the current price target is an average from 2 analysts. New target price is 11% above last closing price of NT$345. Stock is down 14% over the past year. The company is forecast to post earnings per share of NT$18.42 for next year compared to NT$21.68 last year.
Reported Earnings • Mar 15Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: NT$21.68 (up from NT$21.22 in FY 2023). Revenue: NT$6.46b (up 13% from FY 2023). Net income: NT$1.73b (up 2.9% from FY 2023). Profit margin: 27% (down from 30% in FY 2023). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.7%. Revenue is forecast to grow 7.1% p.a. on average during the next 2 years, compared to a 4.9% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 11% per year.
分析記事 • Mar 13Allied Supreme (TWSE:4770) Has Announced A Dividend Of NT$12.00Allied Supreme Corp. ( TWSE:4770 ) has announced that it will pay a dividend of NT$12.00 per share on the 30th of...
お知らせ • Mar 13Allied Supreme Corp., Annual General Meeting, May 29, 2025Allied Supreme Corp., Annual General Meeting, May 29, 2025, at 10:00 Taipei Standard Time. Location: no,300, ch`ing fu rd., siansi township, changhua county Taiwan
Declared Dividend • Mar 13Dividend of NT$12.00 announcedDividend of NT$12.00 is the same as last year. Ex-date: 27th March 2025 Payment date: 30th April 2025 Dividend yield will be 3.5%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by both earnings (56% earnings payout ratio) and cash flows (75% cash payout ratio). The dividend has increased by an average of 29% per year over the past 4 years and payments have been stable during that time. EPS is expected to grow by 19% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Mar 12Allied Supreme Corp. Announces Cash Dividend Distribution for the Year 2024, Payable on April 30, 2025Allied Supreme Corp. announced cash dividend distribution for the year 2024. Type and monetary amount of common stock dividend distribution: Cash dividends: TWD 959,712,000 (TWD 12 distributed per share). Ex-rights (ex-dividend) trading date: March 27, 2025; Ex-rights (ex-dividend) record date: April 4, 2025. Payment date of common stock cash dividend distribution: April 30, 2025.
Valuation Update With 7 Day Price Move • Mar 06Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$372, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 68% over the past three years.
お知らせ • Feb 28Allied Supreme Corp. to Report Q4, 2024 Results on Mar 07, 2025Allied Supreme Corp. announced that they will report Q4, 2024 results on Mar 07, 2025
New Risk • Feb 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Valuation Update With 7 Day Price Move • Feb 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$330, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 40% over the past three years.
分析記事 • Feb 14There's No Escaping Allied Supreme Corp.'s (TWSE:4770) Muted EarningsAllied Supreme Corp.'s ( TWSE:4770 ) price-to-earnings (or "P/E") ratio of 14.9x might make it look like a buy right...
分析記事 • Dec 16Why You Should Care About Allied Supreme's (TWSE:4770) Strong Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...
Reported Earnings • Nov 15Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behindThird quarter 2024 results: EPS: NT$5.28 (up from NT$4.82 in 3Q 2023). Revenue: NT$1.77b (up 44% from 3Q 2023). Net income: NT$422.1m (up 10% from 3Q 2023). Profit margin: 24% (down from 31% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) missed analyst estimates by 5.2%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 9% per year.
お知らせ • Nov 01Allied Supreme Corp. to Report Q3, 2024 Results on Nov 08, 2024Allied Supreme Corp. announced that they will report Q3, 2024 results on Nov 08, 2024
分析記事 • Sep 04Investors Shouldn't Overlook The Favourable Returns On Capital At Allied Supreme (TWSE:4770)What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...
Reported Earnings • Aug 12Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: NT$5.01 (up from NT$4.75 in 2Q 2023). Revenue: NT$1.59b (up 8.4% from 2Q 2023). Net income: NT$400.4m (up 6.6% from 2Q 2023). Profit margin: 25% (in line with 2Q 2023). Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) also missed analyst estimates by 10%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 4.7% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 19% per year and the company’s share price has also increased by 19% per year.
分析記事 • Aug 08A Look At The Intrinsic Value Of Allied Supreme Corp. (TWSE:4770)Key Insights Allied Supreme's estimated fair value is NT$463 based on 2 Stage Free Cash Flow to Equity Allied Supreme's...
Buy Or Sell Opportunity • Aug 05Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to NT$348. The fair value is estimated to be NT$462, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% over the last 3 years. Earnings per share has grown by 25%. Revenue is forecast to grow by 19% in a year. Earnings are forecast to grow by 16% in the next year.
お知らせ • Aug 01Allied Supreme Corp. to Report Q2, 2024 Results on Aug 08, 2024Allied Supreme Corp. announced that they will report Q2, 2024 results on Aug 08, 2024
分析記事 • Jun 26Many Still Looking Away From Allied Supreme Corp. (TWSE:4770)Allied Supreme Corp.'s ( TWSE:4770 ) price-to-earnings (or "P/E") ratio of 19.9x might make it look like a buy right...
Reported Earnings • May 18First quarter 2024 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2024 results: EPS: NT$6.14 (down from NT$6.81 in 1Q 2023). Revenue: NT$1.48b (down 13% from 1Q 2023). Net income: NT$489.9m (down 9.0% from 1Q 2023). Profit margin: 33% (up from 32% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue exceeded analyst estimates by 4.9%. Earnings per share (EPS) also surpassed analyst estimates by 18%. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 6.6% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 22% per year.
分析記事 • May 08Allied Supreme (TWSE:4770) Is Aiming To Keep Up Its Impressive ReturnsFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
お知らせ • May 02Allied Supreme Corp. to Report Q1, 2024 Results on May 09, 2024Allied Supreme Corp. announced that they will report Q1, 2024 results on May 09, 2024
Price Target Changed • Mar 22Price target increased by 14% to NT$419Up from NT$369, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of NT$415. Stock is up 40% over the past year. The company is forecast to post earnings per share of NT$22.89 for next year compared to NT$21.22 last year.
分析記事 • Mar 21We Think That There Are More Issues For Allied Supreme (TWSE:4770) Than Just Sluggish EarningsAllied Supreme Corp.'s ( TWSE:4770 ) stock showed strength, with investors undeterred by its weak earnings report...
Upcoming Dividend • Mar 21Upcoming dividend of NT$12.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 30 April 2024. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 2.8%. Lower than top quartile of Taiwanese dividend payers (4.7%). Lower than average of industry peers (4.1%).
Reported Earnings • Mar 16Full year 2023 earnings: Revenues and EPS in line with analyst expectationsFull year 2023 results: EPS: NT$21.22 (down from NT$22.54 in FY 2022). Revenue: NT$5.69b (down 7.3% from FY 2022). Net income: NT$1.68b (down 5.2% from FY 2022). Profit margin: 30% (in line with FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 8.4% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 33% per year whereas the company’s share price has increased by 34% per year.
Price Target Changed • Mar 13Price target increased by 13% to NT$393Up from NT$348, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of NT$387. Stock is up 21% over the past year. The company is forecast to post earnings per share of NT$21.17 for next year compared to NT$22.54 last year.
分析記事 • Mar 11Allied Supreme (TWSE:4770) Is Paying Out A Dividend Of NT$12.00Allied Supreme Corp.'s ( TWSE:4770 ) investors are due to receive a payment of NT$12.00 per share on 30th of April. The...
Declared Dividend • Mar 10Dividend of NT$12.00 announcedDividend of NT$12.00 is the same as last year. Ex-date: 28th March 2024 Payment date: 30th April 2024 Dividend yield will be 3.1%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by earnings (53% earnings payout ratio) but not covered by cash flows (294% cash payout ratio). The dividend has increased by an average of 41% per year over the past 3 years and payments have been stable during that time. EPS is expected to grow by 14% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Mar 09+ 1 more updateAllied Supreme Corp. Announces Cash Dividend, Payable on April 30, 2024Allied Supreme Corp. announced cash dividend of TWD 959,712,000 (TWD 12 per share). Ex-rights (ex-dividend) trading date: March 28, 2024. Ex-rights (ex-dividend) record date: April 5, 2024. Payment date of common stock cash dividend distribution: April 30, 2024.
Valuation Update With 7 Day Price Move • Feb 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$405, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 24x in the Chemicals industry in Taiwan. Total returns to shareholders of 178% over the past three years.
分析記事 • Feb 26Allied Supreme Corp.'s (TWSE:4770) Low P/E No Reason For ExcitementWith a price-to-earnings (or "P/E") ratio of 16.7x Allied Supreme Corp. ( TWSE:4770 ) may be sending bullish signals at...
Reported Earnings • Nov 17Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2023 results: EPS: NT$4.82 (down from NT$5.91 in 3Q 2022). Revenue: NT$1.23b (down 19% from 3Q 2022). Net income: NT$383.5m (down 18% from 3Q 2022). Profit margin: 31% (in line with 3Q 2022). Revenue missed analyst estimates by 9.7%. Earnings per share (EPS) exceeded analyst estimates by 5.9%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 41% per year whereas the company’s share price has increased by 38% per year.
Valuation Update With 7 Day Price Move • Nov 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$365, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 21x in the Chemicals industry in Taiwan. Total returns to shareholders of 196% over the past three years.
Price Target Changed • Nov 10Price target increased by 8.9% to NT$348Up from NT$319, the current price target is an average from 3 analysts. New target price is 9.5% above last closing price of NT$318. Stock is up 2.4% over the past year. The company is forecast to post earnings per share of NT$21.14 for next year compared to NT$22.54 last year.
Reported Earnings • Aug 10Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: NT$4.75 (down from NT$5.66 in 2Q 2022). Revenue: NT$1.46b (down 8.0% from 2Q 2022). Net income: NT$375.6m (down 15% from 2Q 2022). Profit margin: 26% (down from 28% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 9.2%. Earnings per share (EPS) also missed analyst estimates by 13%. Revenue is forecast to grow 7.6% p.a. on average during the next 2 years, compared to a 5.1% growth forecast for the Chemicals industry in Taiwan.
Price Target Changed • May 11Price target decreased by 16% to NT$339Down from NT$405, the current price target is an average from 2 analysts. New target price is 23% above last closing price of NT$275. Stock is up 4.8% over the past year. The company is forecast to post earnings per share of NT$23.67 for next year compared to NT$22.54 last year.
Reported Earnings • May 10First quarter 2023 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2023 results: EPS: NT$6.81 (up from NT$4.58 in 1Q 2022). Revenue: NT$1.70b (up 23% from 1Q 2022). Net income: NT$538.2m (up 50% from 1Q 2022). Profit margin: 32% (up from 26% in 1Q 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 4.9%. Earnings per share (EPS) also surpassed analyst estimates by 22%. Revenue is forecast to grow 9.7% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Taiwan are expected to remain flat.
Buying Opportunity • Apr 24Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be NT$370, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has grown by 51%. Revenue is forecast to grow by 24% in 2 years. Earnings is forecast to grow by 21% in the next 2 years.
Buying Opportunity • Mar 28Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 10%. The fair value is estimated to be NT$368, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has grown by 51%. Revenue is forecast to grow by 24% in 2 years. Earnings is forecast to grow by 21% in the next 2 years.
Reported Earnings • Mar 24Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: NT$22.54 (up from NT$13.94 in FY 2021). Revenue: NT$6.14b (up 60% from FY 2021). Net income: NT$1.78b (up 84% from FY 2021). Profit margin: 29% (up from 25% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.9%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 2.1% growth forecast for the Chemicals industry in Taiwan.
Price Target Changed • Mar 21Price target decreased by 9.0% to NT$380Down from NT$417, the current price target is an average from 2 analysts. New target price is 29% above last closing price of NT$294. Stock is up 19% over the past year. The company is forecast to post earnings per share of NT$21.48 for next year compared to NT$13.94 last year.
Upcoming Dividend • Mar 17Upcoming dividend of NT$12.00 per share at 2.5% yieldEligible shareholders must have bought the stock before 24 March 2023. Payment date: 28 April 2023. Payout ratio is a comfortable 39% and the cash payout ratio is 96%. Trailing yield: 2.5%. Lower than top quartile of Taiwanese dividend payers (6.2%). Lower than average of industry peers (6.6%).
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Nov 10Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2022 results: EPS: NT$5.91 (up from NT$4.01 in 3Q 2021). Revenue: NT$1.53b (up 48% from 3Q 2021). Net income: NT$467.0m (up 68% from 3Q 2021). Profit margin: 31% (up from 27% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 6.5%. Earnings per share (EPS) exceeded analyst estimates by 7.4%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Taiwan are expected to remain flat.
Valuation Update With 7 Day Price Move • Oct 13Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to NT$285, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in Taiwan. Total returns to shareholders of 32% over the past year. Simply Wall St's valuation model estimates the intrinsic value at NT$567 per share.
Valuation Update With 7 Day Price Move • Aug 22Investor sentiment improved over the past weekAfter last week's 21% share price gain to NT$320, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Chemicals industry in Taiwan. Total returns to shareholders of 51% over the past year. Simply Wall St's valuation model estimates the intrinsic value at NT$595 per share.
Reported Earnings • Aug 13Second quarter 2022 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2022 results: EPS: NT$5.65 (up from NT$3.04 in 2Q 2021). Revenue: NT$1.59b (up 78% from 2Q 2021). Net income: NT$444.2m (up 112% from 2Q 2021). Profit margin: 28% (up from 23% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 9.1%. Earnings per share (EPS) also surpassed analyst estimates by 15%. Over the next year, revenue is forecast to grow 29% compared to a 1.7% decline forecast for the industry in Taiwan.
Reported Earnings • May 12First quarter 2022 earnings: EPS exceeds analyst expectationsFirst quarter 2022 results: EPS: NT$4.58 (up from NT$2.79 in 1Q 2021). Revenue: NT$1.38b (up 81% from 1Q 2021). Net income: NT$359.5m (up 87% from 1Q 2021). Profit margin: 26% (in line with 1Q 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.1%. Over the next year, revenue is forecast to grow 34% while the industry in Taiwan is not expected to grow.
Reported Earnings • Mar 30Full year 2021 earnings released: EPS: NT$13.94 (vs NT$7.65 in FY 2020)Full year 2021 results: EPS: NT$13.94 (up from NT$7.65 in FY 2020). Revenue: NT$3.83b (up 46% from FY 2020). Net income: NT$966.3m (up 84% from FY 2020). Profit margin: 25% (up from 20% in FY 2020). The increase in margin was driven by higher revenue.
Upcoming Dividend • Mar 24Upcoming dividend of NT$8.00 per shareEligible shareholders must have bought the stock before 31 March 2022. Payment date: 29 April 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Taiwanese dividend payers (5.4%). Lower than average of industry peers (6.3%).
Valuation Update With 7 Day Price Move • Dec 31Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$291, the stock trades at a trailing P/E ratio of 22.3x. Average trailing P/E is 19x in the Chemicals industry in Taiwan. Total returns to shareholders of 118% over the past year.
Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS NT$4.01 (vs NT$2.40 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: NT$1.04b (up 37% from 3Q 2020). Net income: NT$277.9m (up 69% from 3Q 2020). Profit margin: 27% (up from 22% in 3Q 2020). The increase in margin was driven by higher revenue.
Reported Earnings • Aug 05First quarter 2021 earnings released: EPS NT$2.79 (vs NT$0.60 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: NT$763.5m (up 83% from 1Q 2020). Net income: NT$191.8m (up 367% from 1Q 2020). Profit margin: 25% (up from 9.8% in 1Q 2020). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • May 18Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to NT$200, the stock trades at a trailing P/E ratio of 26.1x. Average trailing P/E is 15x in the Chemicals industry in Taiwan.
Reported Earnings • Apr 28Full year 2020 earnings released: EPS NT$7.65 (vs NT$7.30 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: NT$2.63b (up 1.8% from FY 2019). Net income: NT$526.4m (up 5.3% from FY 2019). Profit margin: 20% (in line with FY 2019).
分析記事 • Apr 28What Allied Supreme Corp.'s (GTSM:4770) 36% Share Price Gain Is Not Telling YouAllied Supreme Corp. ( GTSM:4770 ) shares have continued their recent momentum with a 36% gain in the last month alone...
Valuation Update With 7 Day Price Move • Apr 21Investor sentiment improved over the past weekAfter last week's 17% share price gain to NT$234, the stock trades at a trailing P/E ratio of 56.2x. Average trailing P/E is 21x in the Chemicals industry in Taiwan.
分析記事 • Apr 16Estimating The Intrinsic Value Of Allied Supreme Corp. (GTSM:4770)In this article we are going to estimate the intrinsic value of Allied Supreme Corp. ( GTSM:4770 ) by projecting its...
お知らせ • Mar 12Allied Supreme Corp., Annual General Meeting, May 28, 2021Allied Supreme Corp., Annual General Meeting, May 28, 2021.
Is New 90 Day High Low • Feb 24New 90-day high: NT$161The company is up 19% from its price of NT$135 on 26 November 2020. The Taiwanese market is also up 19% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is up 10.0% over the same period.
Is New 90 Day High Low • Jan 21New 90-day high: NT$143The company is up 21% from its price of NT$119 on 23 October 2020. The Taiwanese market is also up 21% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is up 11% over the same period.
分析記事 • Dec 28Boasting A 11% Return On Equity, Is Allied Supreme Corp. (GTSM:4770) A Top Quality Stock?Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Valuation Update With 7 Day Price Move • Nov 16Market bids up stock over the past weekAfter last week's 16% share price gain to NT$138, the stock is trading at a trailing P/E ratio of 33.1x, up from the previous P/E ratio of 28.4x. This compares to an average P/E of 18x in the Chemicals industry in Taiwan.
Valuation Update With 7 Day Price Move • Nov 12Market bids up stock over the past weekAfter last week's 15% share price gain to NT$138, the stock is trading at a trailing P/E ratio of 33.1x, up from the previous P/E ratio of 28.7x. This compares to an average P/E of 21x in the Chemicals industry in Taiwan.
